MADISON, Wis.--(BUSINESS WIRE)--TomoTherapy Incorporated (NASDAQ: TTPY) today announced that Addenbrooke’s Hospital in Cambridge, England has begun treating cancer patients with the TomoTherapy® Hi-Art® system. Addenbrooke’s, run by Cambridge University Hospitals NHS Foundation Trust, is the first National Health Service (NHS)-affiliated institution to install the Hi-Art system, an innovative technology solution that uses a CT scanner-based design to deliver image-guided, intensity-modulated radiation therapy (IG/IMRT) from all angles around the patient.
